D.E. Shaw & Co’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-141,202
| Closed | -$2.11M | – | 5225 |
|
|
2022
Q4 | $2.11M | Sell |
141,202
-124,680
| -47% | -$1.73M | ﹤0.01% | 2902 |
|
|
2022
Q3 | $2.19M | Buy |
265,882
+131,726
| +98% | +$1.01M | ﹤0.01% | 2920 |
|
|
2022
Q2 | $880K | Buy |
134,156
+77,644
| +137% | +$376K | ﹤0.01% | 3724 |
|
|
2022
Q1 | $316K | Buy |
56,512
+17,214
| +44% | +$70.9K | ﹤0.01% | 4625 |
|
|
2021
Q4 | $184K | Buy |
+39,298
| New | +$244K | ﹤0.01% | 4911 |
|
|
2020
Q1 | – | Sell |
-3,128
| Closed | -$20K | – | 4450 |
|
|
2019
Q4 | $20K | Buy |
+3,128
| New | +$23K | ﹤0.01% | 3918 |
|
|
2019
Q3 | – | Sell |
-5,620
| Closed | -$38K | – | 4128 |
|
|
2019
Q2 | $38K | Sell |
5,620
-16,259
| -74% | -$139K | ﹤0.01% | 3601 |
|
|
2019
Q1 | $179K | Sell |
21,879
-6,586
| -23% | -$68K | ﹤0.01% | 3420 |
|
|
2018
Q4 | $455K | Buy |
+28,465
| New | +$626K | ﹤0.01% | 3143 |
|
|
2015
Q2 | – | Sell |
-3,481
| Closed | -$50K | – | 3946 |
|
|
2015
Q1 | $50K | Sell |
3,481
-81,094
| -96% | -$886K | ﹤0.01% | 3559 |
|
|
2014
Q4 | $711K | Buy |
84,575
+1,654
| +2% | +$15.1K | ﹤0.01% | 3079 |
|
|
2014
Q3 | $920K | Sell |
82,921
-20,108
| -20% | -$256K | ﹤0.01% | 2879 |
|
|
2014
Q2 | $1.89M | Sell |
103,029
-7,639
| -7% | -$99.4K | ﹤0.01% | 2357 |
|
|
2014
Q1 | $1.66M | Buy |
110,668
+18,143
| +20% | +$326K | ﹤0.01% | 2571 |
|
|
2013
Q4 | $1.7M | Buy |
92,525
+11,160
| +14% | +$223K | ﹤0.01% | 2673 |
|
|
2013
Q3 | $1.68M | Buy |
81,365
+41,560
| +104% | +$952K | ﹤0.01% | 2571 |
|
|
2013
Q2 | $995K | Buy |
+39,805
| New | +$1.7M | ﹤0.01% | 2719 |
|
D.E. Shaw & Co's AVEO Position: Q1 2023 in Review
D.E. Shaw & Co sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 141,202 shares — an estimated $2.11M sold.
D.E. Shaw & Co first reported a position in AVEO in Q2 2013 and held it in 17 quarters. The position peaked at $2.19M in Q3 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.
- D.E. Shaw & Co reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- D.E. Shaw & Co sold 141,202 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $2.11M.
- D.E. Shaw & Co first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 17 quarters.
- D.E. Shaw & Co's AVEO Pharmaceuticals, Inc. position peaked at $2.19M in Q3 2022.
- 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.
Based on D.E. Shaw & Co's 13F filing for Q1 2023, filed 15 May 2023.